SCOPUS 정보 검색 플랫폼

Volumn 19, Issue 6, 2004, Pages 679-681

The co-existence of fabry and celiac diseases: A case report

(7) Tümer, Leyla a Ezgü, Faith S a Hasanoǧlu, Alev a Dalgiç, Buket a Bakkaloǧlu, Sevcan A a Memiş, Leyla a Dursun, Ayşe a

a GAZI UNIVERSITY (Turkey)

Author keywords

Celiac disease; Enzyme therapy; Fabry disease

Indexed keywords

ALPHA GALACTOSIDASE; CARBAMAZEPINE; ENDOMYSIUM ANTIBODY; GLIADIN ANTIBODY;

ANOREXIA; ARTICLE; CASE REPORT; CATCH UP GROWTH; CELIAC DISEASE; COMORBIDITY; CORNEA OPACITY; DISEASE COURSE; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME REPLACEMENT; FABRY DISEASE; FEMALE; FLANK PAIN; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GLUTEN FREE DIET; GROWTH RETARDATION; HETEROZYGOSITY; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; INTESTINE BIOPSY; INTESTINE VILLUS ATROPHY; KIDNEY DISEASE; KIDNEY FAILURE; LABORATORY TEST; LIMB PAIN; MOTHER; NAUSEA AND VOMITING; PARESTHESIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEINURIA; SCHOOL CHILD; SYMPTOM; TREATMENT OUTCOME; VISUAL SYSTEM EXAMINATION; WEIGHT REDUCTION;

ALPHA-GALACTOSIDASE; CELIAC DISEASE; CHILD; FABRY DISEASE; FEMALE; GENETIC DISEASES, X-LINKED; HUMANS; INTESTINAL MUCOSA; MALE; MICROSCOPY, ELECTRON, TRANSMISSION;

EID: 18244417259 PISSN: 0931041X EISSN: None Source Type: Journal
DOI: 10.1007/s00467-004-1462-8 Document Type: Article

Times cited : (17)

References (11)

1
- 0035852488
- Anderson-Fabry disease: α-galactosidase deficiency
- Peters FJP, Vermeulen A, Kho Tl (2001) Anderson-Fabry disease: α-galactosidase deficiency. Lancet 357:138-140
- (2001) Lancet , vol.357 , pp. 138-140
- Peters, F.J.P.¹ Vermeulen, A.² Kho, T.L.³

2
- 0000889058
- α-Galactosidase A deficiency: Fabry disease
- Scriver CR, Beaudet AI, Sly WS, Valle D (eds) 8th edn. McGraw-Hill, New York
- Desnick RJ, Ioannou YA, Eng CM (2001) α-Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AI, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, vol. 3, pp 3733-3774
- (2001) The Metabolic and Molecular Bases of Inherited Disease , vol.3 , pp. 3733-3774
- Desnick, R.J.¹ Ioannou, Y.A.² Eng, C.M.³

3
- 0035667062
- Anderson-Fabry disease: Clinical manifestations of disease in female heterozygotes
- Whybra C, Kampmann C, Willers I, Davis J, Winchester B, Kreigsmann J, Brühl K, Gal A, Bunge S, Beck M (2001) Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes. J Inherited Metab Dis 24:715-724
- (2001) J. Inherited Metab. Dis. , vol.24 , pp. 715-724
- Whybra, C.¹ Kampmann, C.² Willers, I.³ Davis, J.⁴ Winchester, B.⁵ Kreigsmann, J.⁶ Brühl, K.⁷ Gal, A.⁸ Bunge, S.⁹ Beck, M.¹⁰

4
- 0031820331
- X-Chromosome inactivation: A repeat hypothesis
- Lyon MF (1998) X-Chromosome inactivation: a repeat hypothesis. Cytogenet Cell Genet 80:133-137
- (1998) Cytogenet. Cell Genet. , vol.80 , pp. 133-137
- Lyon, M.F.¹

5
- 0019820524
- Gastrointestinal structure and function in Fabry disease
- Sheth KJ, Werlin SL, Freeman ME, Hodach AE (1981) Gastrointestinal structure and function in Fabry disease. Am J Gastroenterol 76:246-251
- (1981) Am. J. Gastroenterol. , vol.76 , pp. 246-251
- Sheth, K.J.¹ Werlin, S.L.² Freeman, M.E.³ Hodach, A.E.⁴

6
- 0016566513
- Occurrence of celiac sprue in a patient with Fabry disease
- Halsted CH, Rowe JW (1975) Occurrence of celiac sprue in a patient with Fabry disease. Ann Intern Med 83:524-525
- (1975) Ann. Intern. Med. , vol.83 , pp. 524-525
- Halsted, C.H.¹ Rowe, J.W.²

7
- 0033582557
- Different phenotypic expression in relatives with Fabry disease caused by a W226X mutation
- Knol IE, Ausems MG, Lindhout D, Diggelen OP van, Verwey H, Davies J, Ploos van Amstel JK, Poll-The BT (1999) Different phenotypic expression in relatives with Fabry disease caused by a W226X mutation. Am J Med Genet 82:436-439
- (1999) Am. J. Med. Genet. , vol.82 , pp. 436-439
- Knol, I.E.¹ Ausems, M.G.² Lindhout, D.³ van Diggelen, O.P.⁴ Verwey, H.⁵ Davies, J.⁶ Ploos van Amstel, J.K.⁷ Poll-The, B.T.⁸

8
- 0036266877
- Natural history and treatment of renal involvement in Fabry disease
- Branton M, Schiffmann R, Kopp JB (2002) Natural history and treatment of renal involvement in Fabry disease. J Am Soc Nephrol 13:S139-S143
- (2002) J. Am. Soc. Nephrol. , vol.13
- Branton, M.¹ Schiffmann, R.² Kopp, J.B.³

9
- 0037234314
- Enzyme replacement therapy for Fabry disease: Proving the clinical benefit
- Breunig F, Wanner C (2003) Enzyme replacement therapy for Fabry disease: proving the clinical benefit. Nephrol Dial Transplant 18:7-9
- (2003) Nephrol. Dial. Transplant. , vol.18 , pp. 7-9
- Breunig, F.¹ Wanner, C.²

10
- 0035816007
- Enzyme replacement therapy in Fabry disease: A randomized controlled trial
- Schiffmann R, Kopp JB, Austin HA 3rd, Sabnis S, Moore DF, Weibel T, Balow JE, Brady RO (2001) Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 285:2743-2749
- (2001) JAMA , vol.285 , pp. 2743-2749
- Schiffmann, R.¹ Kopp, J.B.² Austin III, H.A.³ Sabnis, S.⁴ Moore, D.F.⁵ Weibel, T.⁶ Balow, J.E.⁷ Brady, R.O.⁸

11
- 0035811624
- Safety and efficacy of recombinant human alpha-galactosidase A-replacement therapy in Fabry disease
- Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, Caplan L, Linthorst GE, Desnick RJ (2001) Safety and efficacy of recombinant human alpha-galactosidase A-replacement therapy in Fabry disease. N Engl J Med 345:9-16
- (2001) N. Engl. J. Med. , vol.345 , pp. 9-16
- Eng, C.M.¹ Guffon, N.² Wilcox, W.R.³ Germain, D.P.⁴ Lee, P.⁵ Waldek, S.⁶ Caplan, L.⁷ Linthorst, G.E.⁸ Desnick, R.J.⁹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.